KeyBanc lowered the firm’s price target on GoodRx (GDRX) to $6 from $7 and keeps an Overweight rating on the shares. The firm notes healthcare ...

Analysts have set 12-month price targets for GoodRx Holdings, revealing an average target of $6.25, a high estimate of $7.00, ...

GoodRx returned to sequential growth in subscribers in Q3, showing potential for profit improvement. Read why I upgrade GDRX ...

Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) saw strong trading volume on Friday . 670,223 shares were traded during mid-day trading, an increase of 41% from the previous session’s ...

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets ...

GoodRx operates as a consumer-focused digital healthcare platform, providing services aimed at making healthcare more affordable and accessible. The company's primary offering is a prescription drug ...

GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests ...

One notable example of this is GoodRx Holdings, Inc.’s (NASDAQ:GDRX) partnership with Dexcom, which offers a discounted cash price for the Dexcom G7 diabetes unit. GoodRx Holdings, Inc.

The permanent CEO decision comes as GoodRx faces a lower stock price compared with the same time last year. The company also missed investor expectations on earnings and revenue in the third quarter.

Santa Monica-based prescription drug savings platform GoodRx Holdings Inc. has hired a pharmacy benefits industry veteran as ...

GoodRx operates a telemedicine platform and a website that tracks prescription drug prices and provides coupons for discounts on medications. A national prescription-savings platform based in ...